
WSP to acquire Ricardo, a global strategic and engineering consultancy firm
MONTREAL, June 11, 2025 (GLOBE NEWSWIRE) — WSP Global Inc. (TSX: WSP) ('WSP' or the 'Corporation'), one of the world's leading professional services firms, announces that it has reached agreements to acquire the entire issued and to be issued share capital of Ricardo plc ('Ricardo') for 430 pence (the 'Offer Price') per share (the 'Acquisition'). This Acquisition underscores WSP's commitment to expanding its footprint in high-growth sectors worldwide.
Headquartered in the United Kingdom, Ricardo is a global consulting firm delivering strategic, advisory, and engineering solutions that intersect the global transport, energy, and environment agendas. Operating in over 20 countries, Ricardo is home to approximately 2,700 experts based across Europe, Australia, North America, Asia, and the Middle East. Its activities are grouped under two main portfolios:
Over the last few years, Ricardo has been reorienting its business to become a leading strategic and engineering consultancy firm, focused on its EE and Rail portfolio. Under WSP's ownership, Ricardo will continue its ongoing strategic review of the A&I and PP business units. While no firm decisions have been taken, the outcome of the strategic review is likely to result in a sale of the A&I and PP businesses at the appropriate time.
This Acquisition represents an excellent opportunity for WSP to progress its 2025-2027 Global Strategic Action Plan and accelerate its expansion in targeted high-growth areas. Specialized and differentiated, Ricardo's value-added expertise in rail, air quality, water management, energy resilience, policy strategy, and advisory supplements and elevates WSP's offering in core market sectors. Geographically, Ricardo matches up well with WSP's existing footprint and further strengthens its presence in several key markets, including the UK, Australia, and the Netherlands.
'The proposed acquisition of Ricardo perfectly aligns with WSP's vision for sustainable, compounding growth and our clear ambitions to expand in advisory, energy transition, water solutions, and the rail sector over the next three years,' expressed Alexandre L'Heureux, President and CEO of WSP. 'We are poised to enhance our ability to deliver innovative solutions as we combine our global reach and resources with Ricardo's complementary expertise. Moreover, the shared entrepreneurial spirit and technical excellence between our teams position us to create further value for our clients. We look forward to welcoming Ricardo's talented professionals to WSP and seizing new opportunities with our broadened service offering.'
The Acquisition reflects an enterprise value of approximately £363.1 million (approximately $670 million), which represents a multiple of 10.4x Ricardo's pre-IFRS 16 underlying EBITDA1 for the 12-month period ended December 31, 2024, based on Ricardo's continuing operations after the divestment of their defense business and including the full year contribution of their acquisition of E3A Advisory PTY Ltd.
For further details regarding this announcement, readers are referred to the firm offer announcement in respect of the Acquisition (the 'Announcement') previously released in the United Kingdom on the date hereof in accordance with Rule 2.7 of the UK City Code on Takeovers and Mergers and which can be found on WSP's website at
www.wsp.com/investors
. This press release should be read in conjunction with, and is subject to, the full text of the Announcement.
ACQUISITION AND TIMETABLE
WSP has reached an agreement with the board of Ricardo on the terms of a recommended cash acquisition pursuant to which a wholly owned subsidiary of WSP will acquire the entire issued and to be issued share capital of Ricardo at the Offer Price, excluding a 19.9% interest in Ricardo which WSP will acquire from Science Group plc at the Offer Price on or around June 16, 2025 pursuant to a share purchase agreement dated as of the date hereof (the 'Scheme Acquisition').
WSP has also received undertakings from each of Ricardo's directors and some of its major shareholders in respect of a total number of shares representing in the aggregate approximately 45.1% of Ricardo's issued share capital on June 10, 2025, as well as a letter of intent from a shareholder in respect of a total number of shares representing approximately 3% of Ricardo's issued share capital on June 10, 2025, to vote in favor of the Scheme Acquisition at the Ricardo shareholder meetings to be convened in connection with the Scheme.
It is intended that the Scheme Acquisition will be implemented by means of a Court-sanctioned scheme of arrangement (the 'Scheme') under Part 26 of the UK Companies Act 2006. The purpose of the Scheme is to provide for WSP to, indirectly, via a wholly-owned subsidiary, become the owner of the entire issued and to be issued share capital of Ricardo, other than the shares which WSP will have acquired from Science Group on or around June 16, 2025.
Details of the proposed Scheme Acquisition will be sent to Ricardo shareholders within 28 days of the date of the Announcement (unless the Panel on Takeovers and Mergers under the U.K. City Code on Takeovers and Mergers agrees otherwise). Subject, amongst other things, to the satisfaction or waiver of the conditions, the approval of the Scheme by the Ricardo shareholders, the receipt of applicable regulatory approvals and the Court's sanction of the Scheme, it is expected that the Acquisition will be completed in Q4 2025.
ACQUISITION FINANCING
Concurrently with the announcement of the Acquisition, WSP has obtained a fully committed 'certain funds' £230 million term loan facility (the 'New Credit Facility') (approximately $425 million). The remaining portion of the cash consideration for the Acquisition will be financed through cash on hand and existing credit facilities.
Royal Bank of Canada is acting as lead arranger and sole bookrunner with respect to the New Credit Facility. The New Credit Facility is designed to ensure compliance with the 'certain funds' requirements from the announcement of the Scheme Acquisition under the UK City Code on Takeovers and Mergers.
FINANCIAL AND LEGAL ADVISORS
RBC Capital Markets is acting as financial advisor to WSP on the Acquisition. Legal advice is being provided to WSP by Linklaters LLP internationally.
FORWARD-LOOKING STATEMENTS
In addition to disclosure of historical information, WSP may make or provide statements or information in this press release that are not based on historical or current facts and which are considered to be forward-looking information or forward-looking statements (collectively, 'forward-looking statements') under Canadian securities laws. These forward-looking statements relate to future events or future performance and reflect the expectations of management of WSP ('Management') regarding, without limitation, the growth, results of operations, performance and business prospects and opportunities of WSP or the trends affecting its industry.
Forward-looking statements in this press release include, without limitation, statements about the pending Acquisition by WSP of Ricardo; the conditions precedent to the closing of the Scheme Acquisition; the expected closing date of the Scheme Acquisition; the New Credit Facility; the acquisition of shares from Science Group plc and the timing thereof; the attractiveness of the Acquisition from a financial and strategic perspective; the result of the strategic review of the A&I and PP businesses and the likely outcome of a sale of those business units; other anticipated benefits of the Acquisition and their expected impact on WSP's delivery of its strategic plan and its long-term vision, future growth, results of operations, performance, business, prospects and opportunities, WSP's business outlook, objectives, development, plans, growth strategies and other strategic priorities, and WSP's leadership position in its markets; and statements relating to WSP's future growth, results of operations, performance business, prospects and opportunities. Forward-looking statements can typically be identified by terminology such as 'may', 'will', 'should', 'expect', 'plan', 'anticipate', 'believe', 'estimate', 'predict', 'forecast', 'project', 'intend', 'target', 'potential', 'continue' or the negative of these terms or terminology of a similar nature. Such forward-looking statements reflect current beliefs of Management and are based on certain factors and assumptions, which by their nature are subject to inherent risks and uncertainties. While WSP considers these factors and assumptions to be reasonable based on information available as at the date of this press release, actual events or results could differ materially from the results, predictions, forecasts, conclusions or projections expressed or implied in the forward-looking statements.
Forward-looking statements made by WSP are based on a number of assumptions believed by WSP to be reasonable as at the date of this press release, including assumptions about the satisfaction of all closing conditions; the expected timing of completion of the Acquisition and the conditions precedent to the closing of the Scheme Acquisition (including the approval of the Scheme by the Ricardo shareholders, the receipt of applicable regulatory approvals and the Court's sanction of the Scheme); WSP's ability to retain and attract new business, achieve synergies and maintain market positions arising from successful integration plans relating to the Acquisition; WSP's ability to otherwise complete the integration of Ricardo within anticipated time periods and at expected cost levels; WSP's ability to attract and retain key employees in connection with the Acquisition; Management's estimates and expectations in relation to future economic and business conditions and other factors in relation to the Acquisition and resulting impact on growth and various other financial metrics; Management's expectations in relation to the future performance and economic conditions and other factors in relation to Ricardo; the realization of the expected strategic, financial and other benefits of the Acquisition in the timeframe anticipated; the accuracy and completeness of the information (including financial information) provided by Ricardo and publicly available information; the absence of significant undisclosed costs or liabilities associated with the Acquisition; WSP or Ricardo being adversely impacted during the pendency of the Acquisition; and other factors discussed or referred to in the 'Risk Factors' section of WSP's Management's Discussion and Analysis for the fourth quarter and year ended December 31, 2024 (the '2024 MD&A'), and WSP's Management's Discussion and Analysis for the three-month period ended March 29, 2025 (the 'Q1 2025 MD&A' and together with the 2024 MD&A, the 'MD&As') and filed on SEDAR+ at
www.sedarplus.ca
. If any of these assumptions prove to be inaccurate, WSP's actual results could differ materially from those expressed or implied in forward-looking statements.
WSP's forward-looking statements are expressly qualified in their entirety by this cautionary statement. For additional information on this cautionary note regarding forward-looking statements as well as a description of the relevant assumptions and risk factors likely to affect WSP's actual or projected results, reference is made to the MD&As, which are available on SEDAR+ at
www.sedarplus.ca
. The forward-looking statements contained in this press release are made as of the date hereof and except as required under applicable securities laws, WSP does not undertake to update or revise these forward-looking statements, whether written or verbal, that may be made from time to time by itself or on its behalf, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this press release are expressly qualified by these cautionary statements, as well as other risks detailed from time to time in reports filed by the Corporation with securities regulators or securities commissions or other documents that the Corporation makes public, which may cause events or results to differ materially from the results expressed or implied in any forward-looking statement. As such, there can be no assurance that actual results will be consistent with forward-looking statements.
About WSP
WSP is one of the world's leading professional services firms, uniting its engineering, advisory and science-based expertise to shape communities to advance humanity. From local beginnings to a globe-spanning presence today, WSP operates in over 50 countries and employs approximately 73,000 professionals, known as Visioneers. Together they pioneer solutions and deliver innovative projects in the transportation, infrastructure, environment, building, energy, water, and mining and metals sectors. WSP is publicly listed on the Toronto Stock Exchange (TSX:WSP).
About Ricardo
Ricardo plc is a global strategic, environmental, and engineering consulting company, listed on the London Stock Exchange. With over 110 years of engineering excellence and approximately 2,700 employees in more than 20 countries, Ricardo provides exceptional levels of expertise in delivering innovative cross-sector sustainable outcomes to support energy transition and environmental services, together with safe and smart mobility. Its global team of consultants, environmental specialists, engineers, and scientists support our customers to solve the most complex and dynamic challenges to help achieve a safe and sustainable world.
All dollar figures in this press release are Canadian dollars unless otherwise indicated. Where financial information of Ricardo has been converted from British pounds sterling to Canadian dollars for purposes of comparison to and combination with, financial information of WSP, British pounds sterling have been converted to Canadian dollars at an exchange rate of $1.8462 Canadian dollars per £1.00.
1 Ricardo's pre-IFRS 16 underlying EBITDA means earnings before finance expense, income tax expense, depreciation, and amortization, and includes rent expense and the benefit of major restructuring programs, but excludes significant costs (such as acquisition-related expenditures, reorganization costs, and other specific adjusting items).

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Boralex Appoints Robin Deveaux as Executive Vice President and General Manager, North America
Robin Deveaux Hugues Girardin MONTREAL, June 12, 2025 (GLOBE NEWSWIRE) -- Boralex inc. ('Boralex' or the 'Company') (TSX: BLX) is pleased to announce the appointment of Robin Deveaux as Executive Vice President and General Manager, North America. He succeeds Hugues Girardin, who will retire on December 31, 2025. Until then, M. Girardin will act as Transition Advisor to senior management to ensure a smooth and effective handover of responsibilities. A seasoned finance professional, Robin Deveaux brings over 20 years of experience in the renewable energy and professional services sectors. He is being promoted to Executive Vice President and General Manager after having served as Vice President, Finance, and subsequently as Senior Vice President, Finance and Asset Management for North America at Boralex. Since joining Boralex, Robin has stood out for his inclusive leadership, strategic thinking, and ability to drive projects forward in a fast-evolving environment. These qualities will remain key in his new role, as the Company prepares to unveil its 2030 Strategy. 'I am honoured by the trust placed in me, and I approach this new challenge with a great deal of humility. I have deep respect for Hugues's accomplishments and for the expertise of our teams. Together, we will continue to drive our mission forward — with ambition, discipline, and a strong commitment to collaboration, proximity with the community, and excellence in project execution.,' said Robin Deveaux. See Robin Deveaux's full biography Following an outstanding 34-year career, Hugues Girardin leaves behind a strong and inspiring legacy. A key player in Boralex's growth, he played a major role in developing, building, and promoting the Company's assets. He was consistently driven by a commitment to strengthen community engagement, create lasting value for investors and stakeholders, and unite teams around a common vision. 'It has been a great source of pride to support Boralex's growth over the years and to contribute, in my role, to the development of increasingly innovative renewable energy projects that bring lasting benefits to the regions that host them. I'm pleased to pass the baton to Robin, whose leadership and vision are closely aligned with the Company's ambitions,' said Hugues Girardin. 'I want to sincerely thank Hugues for his unwavering dedication and outstanding contributions to our collective success. I also congratulate Robin on his appointment — his passion for our mission, combined with his expertise, will be tremendous assets for Boralex's future,' concluded Patrick Decostre, President and Chief Executive Officer of Boralex. About Boralex At Boralex, we have been providing affordable renewable energy accessible to everyone for over 30 years. As a leader in the Canadian market and France's largest independent producer of onshore wind power, we also have facilities in the United States and development projects in the United Kingdom. Over the past five years, our installed capacity has increased by more than 50% to 3.2 GW. We are developing a portfolio of projects in development and construction of more than 8 GW in wind, solar and storage projects, guided by our values and our corporate social responsibility (CSR) approach. Through profitable and sustainable growth, Boralex is actively participating in the fight against global warming. Thanks to our fearlessness, discipline, expertise and diversity, we continue to be an industry leader. Boralex's shares are listed on the Toronto Stock Exchange under the ticker symbol BLX. For more information, visit or Follow us on Facebook and LinkedIn. For more information MEDIA Camille LaventureSenior Advisor, Public Affairs and External CommunicationsBoralex inc.438 Photos accompanying this announcement are available at: Source: Boralex inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Rakovina Therapeutics to Attend BIO International Convention to Advance Strategic Partnering Opportunities
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) ('Rakovina' or the 'Company'), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce that members of its executive team will attend the 2025 BIO International Convention, taking place June 16th – 19th in Boston, Massachusetts. Rakovina Therapeutics' management will participate in one-on-one partnering meetings throughout the conference with leading global pharmaceutical and biotechnology companies. The Company will showcase its pipeline of novel DNA damage response (DDR) inhibitors, including drug candidates discovered through its proprietary AI-driven platforms—Deep Docking and Variational AI's generative technology. These collaborations have produced promising compounds with potential applications in DDR-targeted oncology therapies, including candidates capable of penetrating the blood-brain barrier and addressing significant unmet medical needs in the treatment of cancer. KT-3000 Series The KT-3000 series is a novel class of dual-function small molecule inhibitors combining PARP and histone deacetylase (HDAC) inhibition in a single agent. Published pre-clinical data demonstrate that lead candidates for the kt-3000 series retain anti-tumor activity in cancers that are resistant to treatment with FDA-approved PARP inhibitors. The KT-3000 program presents an attractive partnering opportunity for companies seeking to expand their oncology portfolios with multi-functional agents that can be developed across a range of solid tumor indications. Rakovina is actively exploring collaborations to accelerate development and broaden the clinical utility of this program. KT-2000AI Series The KT-2000 series features highly selective PARP1 inhibitors designed to penetrate the blood-brain-barrier, addressing a critical unmet need in the treatment of primary and metastatic brain tumors. The Company previously announced that it had used its proprietary AI algorithm to screen billions of potential drug candidates to identify potential best-in-class lead candidates. By targeting PARP1 specifically—while sparing PARP2—the KT-2000 compounds are anticipated to deliver potent anti-tumor activity with an improved safety profile. The program is well positioned for strategic partnerships focused on advancing therapies for glioblastoma and other CNS-involved cancers, where few targeted options exist. KT-5000AI Series The KT-5000 series focuses on highly selective ATR inhibitors, a key target in the DNA damage response pathway. ATR inhibition has emerged as a promising strategy to exploit tumor vulnerabilities in cancers. Rakovina's AD-derived KT-5000 candidates are engineered for optimal selectivity and tolerability, positioning them for combination use with other DDR-targeted agents or standard-of-care therapies. The program represents a significant opportunity to address a wide range of solid tumors with high unmet medical need. 'The Rakovina Therapeutics team has advanced multiple programs from discovery to pre-clinical validation in our laboratories at the University of British Columbia. We look forward to engaging with potential partners who share our vision of accelerating breakthrough therapies through the integration of artificial intelligence and oncology expertise,' said Jeffrey Bacha, Executive Chairman. 'BIO provides an opportunity to both continue and initiate strategic discussions to drive long-term value through collaboration.' Rakovina's platform has already attracted interest from multiple pharmaceutical companies seeking differentiated assets and AI-powered discovery capabilities. The Company anticipates that upcoming milestones—including lead optimization data and new target nominations—will further enhance its strategic positioning. For more information or to schedule a meeting with Rakovina Therapeutics management at BIO, please contact: Michelle Seltenrich, Director, Corporate Development – About BIO International Convention The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe. In a time of remarkable discovery and progress, the biotechnology industry stands at the forefront of a revolution changing how we live, heal, and care. From pioneering treatments offering hope to millions, to sustainable agricultural innovations to feed a growing population, or environmental breakthroughs securing our future, biotech drives positive change faster than ever. This progress is not just a change but a promise for a brighter future. The world is ready. For more information: About Rakovina Therapeutics Therapeutics is a biopharmaceutical research company focused on the development of innovative cancer treatments. Our work is based on unique technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using the proprietary Deep-Docking™ and Enki™ platforms. By using AI, we can review and optimize drug candidates at a much greater pace than ever before. The Company has established a pipeline of distinctive DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners. Further information may be found at Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. Notice Regarding Rakovina Therapeutics Forward-Looking Statements: This release includes forward-looking statements regarding the company and its respective business, which may include, but is not limited to, statements with respect to the proposed business plan of the company and other statements. Often, but not always, forward-looking statements can be identified by the use of words such as 'plans,' 'is expected,' 'expects,' 'scheduled,' 'intends,' 'contemplates,' 'anticipates,' 'believes,' 'proposes' or variations (including negative variations) of such words and phrases, or state that certain actions, events, or results 'may,' 'could,' 'would,' 'might,' or 'will' be taken, occur, or be achieved. Such statements are based on the current expectations of the management of the company. The forward-looking events and circumstances discussed in this release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the company, including risks regarding the medical device industry, economic factors, regulatory factors, the equity markets generally, and risks associated with growth and competition. Although the company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events, or results to differ from those anticipated, estimated, or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made, and the company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. The reader is referred to the company's most recent filings on SEDAR for a more complete discussion of all applicable risk factors and their potential effects, copies of which may be accessed through the company's profile page at For Further Information Contact:Michelle Seltenrich, BSc MBADirector, Corporate DevelopmentIR@ in to access your portfolio
Yahoo
an hour ago
- Yahoo
New Found Gold Closes Second Tranche of C$63 Million Bought Deal Financing Including Full Exercise of Underwriters' Over-Allotment Option
VANCOUVER, BC, June 12, 2025 /CNW/ - New Found Gold Corp. (TSXV: NFG) (NYSE-A: NFGC) ("New Found Gold" or the "Company") is pleased to announce that it has closed the second and final tranche of its previously announced "bought deal" public offering of (i) 24,610,000 charity flow-through common shares of the Company (the "Charity Flow-Through Common Shares") that will qualify as "flow-through shares" (within the meaning of subsection 66(15) of the Income Tax Act (Canada)) at a price of C$2.29 per Charity Flow-Through Common Share (the "Charity Flow-Through Common Share Offering Price"), including the exercise, in full, of the Underwriters' (as defined below) over-allotment option (the "Over-Allotment Option") of 3,210,000 Charity Flow-Through Common Shares, and (ii) 4,370,000 common shares (the "Common Shares") at a price of C$1.63 per Common Share, for aggregate gross proceeds of C$63,480,000 (the "Offering"). The second tranche of the Offering consists of 9,345,000 Charity Flow-Through Common Shares, including the exercise in full of the Over-Allotment Option, for gross proceeds of C$21,400,050. The second tranche of the Offering was completed pursuant to an underwriting agreement dated May 29, 2025 (the "Underwriting Agreement"), entered into among the Company and a syndicate of underwriters led by BMO Capital Markets and SCP Resource Finance LP and including Paradigm Capital Inc., Canaccord Genuity Corp., Haywood Securities Inc., Stifel Nicolaus Canada Inc., Roth Canada, Inc., A.G.P. Canada Investments ULC and ATB Securities Inc. (collectively, the "Underwriters"). Mr. Eric Sprott participated in the second tranche of the Offering to maintain his approximate 19% shareholdings. The Offering remains subject to the Company receiving all necessary regulatory approvals, including final approval of the TSX Venture Exchange (the "TSXV") to list the Charity Flow-Through Common Shares and the Common Shares. In connection with the closing of the second tranche of the Offering, the Company paid to the Underwriters a cash fee in the aggregate amount of C$526,413.75, representing (i) 5.25% of the gross proceeds of the second tranche of the Offering, other than the gross proceeds raised from certain sales pursuant to a president's list (the "President's List Sales"); and (ii) 1.0% of the gross proceeds raised from President's List Sales. BMO Capital Markets, SCP Resource Finance LP, Paradigm Capital Inc., Canaccord Genuity Corp., Haywood Securities Inc., Stifel Nicolaus Canada Inc., Roth Canada, Inc., A.G.P. Canada Investments ULC and ATB Securities Inc. received C$202,669, C$176,349, C$52,641, C$28,953, C$15,792, C$15,792, C$13,160, C$10,528 and C$10,528, respectively. The gross proceeds from the offering of the Charity Flow-Through Common Shares will be used by the Company to incur eligible "Canadian exploration expenses" that qualify as "flow-through mining expenditures" (as such terms are defined in the Income Tax Act (Canada)) (the "Qualifying Expenditures") related to the Company's 100% owned Queensway Gold Project ("Queensway" or the "Project"), on or before December 31, 2026. All Qualifying Expenditures will be renounced in favour of the subscribers for the Charity Flow-Through Common Shares effective on or before December 31, 2025. The Charity Flow-Through Common Shares were offered by way of a prospectus supplement in each of the Provinces and Territories of Canada (other than the Province of Quebec and Nunavut) and were also offered by way of a U.S. prospectus supplement forming part of the Company's registration statement on Form F-10 in the United States. Copies of the prospectus supplement and documents incorporated by reference therein are available electronically on the Canadian Securities Administrators' System for Electronic Data Analysis and Retrieval+ ("SEDAR+") ( and the SEC's Electronic Data Gathering and Retrieval System ("EDGAR") ( under New Found Gold's issuer profile. Certain directors and officers of the Company participated, directly or indirectly, in the Offering and, due to his shareholdings, Mr. Sprott is considered a "related party" of New Found Gold. Accordingly, their participation in the Offering constitutes "a related party transaction" within the meaning of Multilateral Instrument 61-101 – Protection of Minority Shareholder Approval ("MI 61-101"). The Company has relied on the exemptions from valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of such related party participation. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. About New Found Gold New Found Gold holds a 100% interest in Queensway, located in Newfoundland and Labrador, a Tier 1 jurisdiction with excellent infrastructure and a skilled local workforce. The Company has completed an initial mineral resource estimate at Queensway (see New Found Gold news release dated March 24, 2025). A fully funded preliminary economic assessment is underway, with completion scheduled for late Q2/25. Recent drilling continues to yield new discoveries along strike and down dip of known gold zones, pointing to the district-scale potential of the 175,600 hectare project that covers a 110 km strike extent along two prospective fault zones. New Found Gold has a new management team in place, a solid shareholder base, which includes a 19% holding by Eric Sprott, and is focused on growth and value creation at Queensway. Please see the Company's SEDAR+ profile at and the Company's EDGAR profile at Keith Boyle Chief Executive Officer New Found Gold Corp. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Information This press release contains certain "forward-looking statements" within the meaning of Canadian and U.S. securities legislation (including the Private Securities Litigation Reform Act of 1995), including statements relating to the use of proceeds of the Offering, the tax treatment of the Charity Flow-Through Common Shares, the receipt of all necessary regulatory approvals in connection with the Offering and, statements related to Queensway and the Company's planned and future exploration at Queensway. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "aims", "suggests", "potential", "goal", "objective", "prospective", "preliminary," "possibly", and similar expressions, or that events or conditions "will", "would", "may", "can", "could" or "should" occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made, and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Except to the extent required by applicable securities laws and the policies of the TSXV or the NYSE American LLC, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change. Factors that could cause future results to differ materially from those anticipated in these forward-looking statements include risks related to: the tax treatment of the Charity Flow-Through Common Shares, the possibility that the Company may not be able to secure permitting and other governmental clearances necessary to carry out the Company's exploration plans, the risk that the Company will not be able to raise sufficient funds to carry out its business plans, and the risk of political uncertainties and regulatory or legal changes that might interfere with the Company's business and prospects. The reader is urged to refer to the Company's Annual Information Form, Management's Discussion and Analysis and other reports and documents filed by the Company with applicable securities regulatory authorities from time to time, publicly available through the SEDAR+ at or through the EDGAR at for a more complete discussion of such risk factors and their potential effects. View original content to download multimedia: SOURCE New Found Gold Corp. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data